Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Industry News

Related Searches:

Filter by:

Abbott To Co-Promote AstraZeneca's Crestor
August 14, 2008
Abbott and AstraZeneca have entered into an agreement for Abbott to promote AZ's cholesterol drug Crestor. Under the terms of the agreement, Abbott will obtain the non-exclusive right to promote the drug alongside AZ in the U.S., excluding Puerto Ric…   Read More »
Stora Enso Signs Pharma DDS Partnerships
August 14, 2008
Stora Enso has signed the first Pharma DDS packaging license agreements in the U.S. and in Europe. The company will partner with Sharp Corp. to package pharmaceutical products into Pharma DDS cartons. An agreement has also been reached with Cadmus Wh…   Read More »
CSL To Acquire Talecris
August 13, 2008
CSL Ltd. has signed an agreement to acquire Talecris Biotherapeutics Holdings Corp. for $3.1 billion, enhancing its position in the global plasma market. Talecris produces plasma medicines in the U.S. and operates 56 plasma collection centers and two…   Read More »
Schering-Plough Establishes Shanghai Operation
August 12, 2008
Schering-Plough has expanded its presence in China by establishing Shanghai Schering-Plough Pharmaceutical Co. Ltd. A wholly-owned operation based in Shanghai, the unit was formed through the acquisition of shares of its former joint venture partners…   Read More »
DSM To Manufacture Antibody For MorphoSys
August 12, 2008
DSM Biologics and MorphoSys AG signed a biopharmaceutical manufacturing agreement covering process development and cGMP manufacturing of MOR202, a fully human HuCAL antibody being studied for the treatment of multiple myeloma. DSM will manufacture MO…   Read More »
UCB Outsources Med-Chem Program To BioFocus DPI
August 12, 2008
BioFocus DPI, Galapagos' service division, has signed a contract with UCB to supply chemistry services in the UK for one of UCB's medicinal chemistry programs. The total contract value for Galapagos could potentially exceed $6 million. Galapagos is a…   Read More »
Enzon May Sell Specialty Pharma Unit
August 11, 2008
Enzon Pharmaceuticals is exploring strategic options for its specialty pharmaceuticals business. These options include selling the entire specialty business or selling one or more of Enzon's marketed products, Oncaspar, DepoCyt, Abelcet and Adagen, a…   Read More »
CMC Biologics, Symphogen Enter Manufacturing Pact
August 8, 2008
CMC Biologics has entered into an agreement with Symphogen for process development and cGMP manufacture of an undisclosed polyclonal antibody product candidate from Symphogen’s development pipeline. Terms of the agreement were not disclosed. &…   Read More »
Valeant, Meda Form JV
August 7, 2008
Valeant Pharmaceuticals and Meda AB have agreed to form joint ventures in Australia, Canada and Mexico to develop, market and commercialize certain current and future products. The joint ventures will be majority-owned by Meda; Valeant will own a min…   Read More »
Meda Acquires Valeant Business In Europe
August 4, 2008
Meda has signed an agreement to acquire Valeant’s pharmaceutical business in western and eastern Europe. The acquisition will give Meda an entry into the Russian market. In Eastern Europe, it means a potential for significant market synergies w…   Read More »
Bilcare GCS Opens Global HQ In U.S.
August 1, 2008
Bilcare Global Clinical Supplies has opened its new global U.S. headquarters in San Francisco, CA. The headquarters, which will be led by chief executive officer Vito Mangiardi, operates as the company's corporate hub to drive growth in Bilcare's Ame…   Read More »
Bristol-Myers Squibb Bids For ImClone
July 31, 2008
Bristol-Myers Squibb has offered approximately $4.5 billion to buy ImClone, its development partner in cancer treatment Erbitux. BMS already owns 17% of ImClone shares through its development deal, so the all-cash offer puts a 30% premium on ImClone'…   Read More »
Bridge To Build Second Beijing Lab
July 30, 2008
Bridge Laboratories has reached an agreement to build its second preclinical facility in China. This purpose-built, 150,000-sq.-ft. facility will be adjacent to the company's existing laboratory in the Zhongguancun Life Science Park located in Beijin…   Read More »
Sanofi-Aventis To Buy Acambis
July 28, 2008
Sanofi-Aventis has offered $550 million to buy out UK-based vaccine maker Acambis. Acambis' board has agreed to the acquisition. Sanofi's vaccine division, Sanofi Pasteur, has worked with Acambis for more than a decade and is currently partnered with…   Read More »
Azopharma Adds Formulations Equipment
July 25, 2008
Azopharma Product Development Group, Inc. has added new equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, FL. The company added the MG Futura Capsule Filler and Bausch & Strobel Aseptic Fil…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: